Teladoc Health Inc buy Royal Bank of Canada
Start price
24.01.25
/
50%
€9.70
Target price
24.01.26
€11.43
Performance (%)
-36.37%
Price
17.12.25
€6.17
Summary
This prediction is currently active. Massive losses of -36.37% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 24.01.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teladoc Health Inc | -6.201% | -6.201% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.29
26.04.24
26.04.24
€16.82
26.04.25
26.04.25
-48.06%
27.04.25
27.04.25
Teladoc Health Inc
Start price
Target price
Perf. (%)
€14.32
21.02.24
21.02.24
€23.12
21.02.25
21.02.25
-24.01%
22.02.25
22.02.25
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-52.00%
26.10.24
26.10.24